PROMETHEUS BIOSCIENCES, INC. Net Income
PROMETHEUS BIOSCIENCES, INC. reported Net Income of -$40.88 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$40.88M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2022-12-31 was -$38.76M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$37.27M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for the quarter ending 2022-06-30 was -$33.65M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2022 was -$141.75M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2021 was -$90.19M.
- PROMETHEUS BIOSCIENCES, INC. net income (loss) attributable to parent for fiscal 2020 was -$37.14M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$40.88M 10-Q · filed 2023-05-09 | -$79.64M derived: sum of 2 quarters · filed 2023-05-09 | -$116.92M derived: sum of 3 quarters · filed 2023-05-09 | -$150.56M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | -$38.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$76.04M derived: sum of 2 quarters · filed 2023-02-28 | -$109.69M derived: sum of 3 quarters · filed 2023-02-28 | -$141.75M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$37.27M 10-Q · filed 2022-11-09 | -$70.92M derived: sum of 2 quarters · filed 2022-11-09 | -$102.99M 10-Q · filed 2022-11-09 | -$132.91M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | -$33.65M 10-Q · filed 2022-11-09 | -$65.71M 10-Q · filed 2022-08-11 | -$95.63M derived: sum of 3 quarters · filed 2023-05-09 | -$122.96M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | -$32.07M 10-Q · filed 2023-05-09 | -$61.98M derived: sum of 2 quarters · filed 2023-05-09 | -$89.32M derived: sum of 3 quarters · filed 2023-05-09 | -$108.32M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$29.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$57.25M derived: sum of 2 quarters · filed 2023-02-28 | -$76.25M derived: sum of 3 quarters · filed 2023-02-28 | -$90.19M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$27.33M 10-Q · filed 2022-11-09 | -$46.33M derived: sum of 2 quarters · filed 2022-11-09 | -$60.28M 10-Q · filed 2022-11-09 | -$68.90M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$19.00M 10-Q · filed 2022-11-09 | -$32.94M 10-Q · filed 2022-08-11 | -$41.57M derived: sum of 3 quarters · filed 2023-02-28 | -$48.51M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$13.95M 10-Q · filed 2022-11-09 | -$22.57M derived: sum of 2 quarters · filed 2023-02-28 | -$29.52M derived: sum of 3 quarters · filed 2023-02-28 | -$37.95M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$15.57M derived: sum of 2 quarters · filed 2023-02-28 | -$24.01M derived: sum of 3 quarters · filed 2023-02-28 | -$37.14M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$6.95M 10-Q · filed 2021-11-12 | -$15.39M derived: sum of 2 quarters · filed 2021-11-12 | -$28.52M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$8.44M 10-Q · filed 2021-11-12 | -$21.57M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$13.13M 10-Q · filed 2021-11-12 |